- Home
- WEX vs PCVX Comparison
WEX vs PCVX Comparison
Compare WEX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEX
- PCVX
- Stock Information
- Founded
- WEX 1983
- PCVX 2013
- Country
- WEX United States
- PCVX United States
- Employees
- WEX N/A
- PCVX N/A
- Industry
- WEX Business Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- WEX Consumer Discretionary
- PCVX Health Care
- Exchange
- WEX Nasdaq
- PCVX Nasdaq
- Market Cap
- WEX 5.8B
- PCVX 6.0B
- IPO Year
- WEX 2005
- PCVX 2020
- Fundamental
- Price
- WEX $148.22
- PCVX $49.61
- Analyst Decision
- WEX Hold
- PCVX Strong Buy
- Analyst Count
- WEX 13
- PCVX 7
- Target Price
- WEX $172.92
- PCVX $101.67
- AVG Volume (30 Days)
- WEX 456.3K
- PCVX 1.4M
- Earning Date
- WEX 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- WEX N/A
- PCVX N/A
- EPS Growth
- WEX N/A
- PCVX N/A
- EPS
- WEX 7.64
- PCVX N/A
- Revenue
- WEX $2,624,500,000.00
- PCVX N/A
- Revenue This Year
- WEX $1.59
- PCVX N/A
- Revenue Next Year
- WEX $4.91
- PCVX N/A
- P/E Ratio
- WEX $19.36
- PCVX N/A
- Revenue Growth
- WEX N/A
- PCVX N/A
- 52 Week Low
- WEX $110.45
- PCVX $27.66
- 52 Week High
- WEX $191.43
- PCVX $94.76
- Technical
- Relative Strength Index (RSI)
- WEX 51.33
- PCVX 65.33
- Support Level
- WEX $133.65
- PCVX $47.02
- Resistance Level
- WEX $150.81
- PCVX $50.27
- Average True Range (ATR)
- WEX 4.45
- PCVX 2.03
- MACD
- WEX 1.37
- PCVX 0.15
- Stochastic Oscillator
- WEX 84.56
- PCVX 93.32
About WEX WEX Inc. common stock
WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.